The Sleep Network on LinkedIn – evidence-based knowledge about sleep
With a LinkedIn campaign, the Sleep Network is raising awareness about the importance of sleep for health, prevention, and quality of life.
FOPH publishes HTA report on valerian
The Federal Office of Public Health (FOPH) has evaluated the evidence on valerian-containing medicines for insomnia, psychological stress, and test anxiety as part of a Health Technology Assessment (HTA). The report concludes that most studies do not demonstrate convincing efficacy. Only for sleep quality were there indications of an advantage over placebo; however, the overall evidence was deemed insufficient. At the same time, the FOPH estimates that the discontinuation of reimbursement would result in savings of over CHF 200 million within five years.
Sleep Network at the Health Day for Parliamentarians
At the Health Day for members of the Swiss Parliament, the Sleep Network provided information on the importance of sleep for health, prevention, and economic costs. The discussions showed the growing interest in sleep as a health and socio-political issue.
Our newly developed fact sheets on sleep and sleep health were made available to participants and met with interest. The fact sheets are now available for download on our website.
URBASAN: How does our living environment affect health, well-being, and sleep?
How does our living environment affect health, well-being, and sleep? The research project URBASAN examines the links between the environment and health in the Neuchâtel mountains and is currently seeking participants. The findings are intended to help shape the health-promoting living environments of the future.
Activity Report Sleep Network 2025
This report provides an overview of the Sleep Network’s activities in 2025 and an outlook on the projects planned for 2026.
Sleep Chatbot – Test now
On behalf of Health Promotion Switzerland, Beobachter Verlag, in collaboration with the Sleep Network, has developed a sleep-themed chatbot that can be tested in the coming months.
All content underpinning the Sleep Chatbot was provided or reviewed by experts from the Sleep Network. The Sleep Chatbot is available to everyone free of charge and without login or registration.
New study: Predicting subsequent diseases from sleep data using an AI model
The study shows that an AI model can predict the risk of more than 130 diseases based on just one night of sleep data, including dementia, heart attack, and stroke. The basis is extensive measurements of various body signals such as brain activity, breathing, and heart rhythm.
The results underscore how closely sleep and health are linked and the potential of systematically analyzing sleep data.
Sleep disorders cost Switzerland 15 billion
Medical treatments, reduced performance, illness-related absences, long-term inability to work: poor sleep among the Swiss population is costing our healthcare system and our economy dearly. A recent study puts a figure on the direct and indirect costs of sleep disorders.
Sleep of young people under pressure: New data from Switzerland
Current data from KidsHealthCH, based among other things on the Swiss Health Survey (SGB), the HBSC study and the Swiss Addiction Monitoring, show an unfavorable development in the sleep of young people:
Among 15- to 24-year-olds, the proportion with pathological or moderate sleep disorders has increased significantly since 2017. In 2022, 28% were affected. Girls and young women report sleep disorders more frequently than boys and young men.
Among 14- to 15-year-olds, too, the proportion with the recommended sleep duration of at least eight hours is slightly declining.
Innsbruck Sleep Summit 2026
The Innsbruck Sleep Summit 2026 brings together international experts to explore current developments in sleep medicine from an interdisciplinary perspective.
Keynotes by Claudio Bassetti, Diego Golombek, and Carlos Schenck provide insights into neurology, chronobiology, and REM sleep research.
The focus is on interdisciplinary exchange and new impulses for the future of sleep medicine.